Home
    • Plans Blog Contact
    Ingevity logo

    Ingevity

    NGVT
    Last price US$76.77
    Market cap US$2.5b
    12M price change 39.35%
    Loading the 12-month Mave Thesis and 1-month news signal

    Industry and sector peers, plus broader research alternatives

    View comparison
    Linde PLCLIN Industry peer NEWMARKET CORPNEU Industry peer Sherwin-Williams CoSHW Industry peer Apple IncAAPL Research alternative
    Overview Earnings Report Price History News Competitors Earnings per Share Return on Equity Net Margin Share Buyback Leverage Financial Statements Financial Ratio
    Dashboard Funda..tals Prediction Screener Map

    Ingevity Overview

    Industry: Specialty Chemicals

    Sector: Basic Materials

    Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products primarily for use in gasoline vapor emission control systems in cars, motorcycles, trucks, and boats. This segment also produces other activated carbon products for use in various applications, including food, water, beverage, and chemical purification. The Performance Chemicals segment comprises of pavement technologies, industrial specialties, and engineered polymers. It manufactures products derived from crude tall oil and lignin extracted from the kraft pulping process, as well as caprolactone monomers and derivatives derived from cyclohexanone and hydrogen peroxide. This segment's products are used in various applications comprising warm mix paving, pavement preservation, pavement reconstruction and recycling, road striping, oil well service additives, oil production, and downstream applications; and adhesives, agrochemical dispersants, lubricants, printing inks, industrial intermediates and oilfield, coatings, resins, elastomers, bioplastics, and medical devices. The company was founded in 1964 and is headquartered in North Charleston, South Carolina. Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment Read More

    Mavefund brings filings, fundamentals, valuation, price history and news for Ingevity into one research view. The sections below show what strengthens or weakens the research case.

    Score

    Reported Results

    What the company reported, with filing details kept small.

    Filed Jul 29, 2026

    Quarterly result summary

    Net sales was $314.1M (reported); EPS was $5 (reported).

    Net sales $314.1M reported
    EPS $5 reported
    Net income $35.3M -124% YoY
    Adjusted EBITDA $25.4M reported

    What changed

    • Net sales reported to $314.1M; EPS reported to $5.
    • Net income -124% YoY to $35.3M.
    • Net sales of $314.1 million decreased 5% from prior year; excluding Road Markings, sales increased 5%.

    Guidance / outlook

    No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.

    Earnings release Open filing

    Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.

    Other recent earnings materials
    SEC filing 10-Q Jul 30, 2026 SEC filing 10-Q May 07, 2026 Earnings release Earnings release May 06, 2026 SEC filing 10-K Feb 26, 2026 Earnings release Earnings release Feb 25, 2026 Earnings release Earnings release Feb 25, 2026 SEC filing 10-Q Nov 06, 2025 Earnings release Earnings release Nov 05, 2025 SEC filing 10-Q Aug 05, 2025 Earnings release Earnings release Aug 04, 2025

    Prediction-grade evidence

    Recent News

    Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.

    Earnings Per Share

    Score 2.00/5
    Ingevity earns a low score, as its Earnings Per Share (EPS) has not shown continuous growth over the last six years. Notable counterparts in the sector with high scores includes Linde PLC NEWMARKET CORP Sherwin-Williams Co
    In Specialty Chemicals industry , Linde PLC , NEWMARKET CORP , Sherwin-Williams Co are companies with high ratings.

    Return on Equity

    Score 1.42/5
    Ingevity exhibits a lower score in the Return on Equity (ROE) section, falling below the sector median value and indicating a comparatively weaker performance in this metric. The top companies in the same sector include Linde PLC NEWMARKET CORP Sherwin-Williams Co
    Ingevity NGVT US$2.5b
    Linde PLC LIN US$246.2b
    NEWMARKET CO... NEU US$7.0b
    Sherwin-Will... SHW US$82.8b

    Net Margin

    Score 1.46/5
    Ingevity olds a low score as its net margin consistently trails below the sector median value and doesn't exhibit continuous growth over the last six years; notable companies in the sector with commendable scores include Linde PLC NEWMARKET CORP Sherwin-Williams Co
    Ingevity NGVT US$2.5b
    Linde PLC LIN US$246.2b
    NEWMARKET CO... NEU US$7.0b
    Sherwin-Will... SHW US$82.8b

    Share Buyback

    In Specialty Chemicals industry , Linde PLC , NEWMARKET CORP , Sherwin-Williams Co are companies with high ratings.

    Leverage

    Score 1.23/5
    Ingevity registers a lower score in the category as a result of its elevated leverage ratio over the past six years compared to the sector median value. Conversely, other companies in the same sector, including Linde PLC NEWMARKET CORP Sherwin-Williams Co have achieved high scores.
    Ingevity NGVT US$2.5b
    Linde PLC LIN US$246.2b
    NEWMARKET CO... NEU US$7.0b
    Sherwin-Will... SHW US$82.8b

    Financial Statements

    Company-reported SEC EDGAR facts organized into the three core statements.

    Reported currency
    Verified SEC statements load when this section enters view.

    Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

    Financial Ratio

    Yearly Quarterly

    Financial
    Profitability
    Growth
    Cash Flow
    Financial Health
    Efficiency Ratios

    Ingevity logo

    Ingevity

    US$76.77

    US$129.30

    +68.4% vs price

    US$2.5b

    -1.29%

    39.35%